TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
RCKT

Rocket Pharmaceuticals Inc

Healthcare · Biotechnology

3.00$ -9.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

Rocket Pharmaceuticals Inc (RCKT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -190 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow RCKT
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-6.9 -6.5 -9.7 -17 -37 -26 -54 -65 -75 -121 -178 -195 -210 -190
0.0 0.1 0.0 0.2 0.2 0.3 0.4 1.1 5.4 6.3 7.1 9.4 11
0.5 -0.1 0.2 2.4 2.9 4.0 14 13 19 29 31 39 44 37
1.3 50 3.1 5.1 14 13 45 45 31
-1.6 0.7 -1.5 0.7 2.1 -2.0 4.4 -3.7 15 -3.4 6.1 13 1.9 -8.3
0.0 0.0 0.4 0.4 0.5 0.1 1.5 23 29 7.7 8.6 16 5.9 0.4
0.0 -32 -32 -66 75 -5.3 -39 -97 19 -69 -98 132 104
0.0 0.2 0.0 5.6 0.2
0.0 112 0.2 0.0 -0.7 0.7 -0.1 38 0.0 0.0 0.0 -0.1
0.6 13 49 -0.2
2.5 18 0.6 126 0.0 0.0 154 178 283 38 155 208 186 0.1
-4.4 11 -9.2 76 -50 49 94 74 112 -65 -92 -85 108 -86
-6.9 -6.5 -9.7 -18 -38 -26 -55 -88 -104 -129 -187 -211 -216 -190

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?